ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 595,41
1,55%
Dow Jones
39 118,86
-0,12%
DAX
18 302,65
0,38%
Brent Oil
85,425
0,37%
Bitcoin
62 699,49
0,16%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Imago BioSciences Inc (IMGO)

  7. Imago BioSciences Inc (IMGO) Actualités

IMGO

Imago BioSciences (IMGO)

Imago BioSciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IMGO
DateHeureSourceTitreSymboleSociété
14/02/202314h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGOImago BioSciences Inc
23/01/202313h26Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:IMGOImago BioSciences Inc
17/01/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IMGOImago BioSciences Inc
12/01/202322h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202322h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGOImago BioSciences Inc
11/01/202316h42Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:IMGOImago BioSciences Inc
11/01/202315h25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGOImago BioSciences Inc
11/01/202315h19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:IMGOImago BioSciences Inc
11/01/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGOImago BioSciences Inc
11/01/202314h58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202314h51Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:IMGOImago BioSciences Inc
20/12/202222h05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in MyelofibrosisNASDAQ:IMGOImago BioSciences Inc
12/12/202217h30GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202216h00GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202214h22Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:IMGOImago BioSciences Inc
12/12/202212h54Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:IMGOImago BioSciences Inc
12/12/202212h45Business WireMerck Begins Tender Offer to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
30/11/202222h05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaNASDAQ:IMGOImago BioSciences Inc
22/11/202212h30TipRanksAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Imago BioSciences (IMGO)NASDAQ:IMGOImago BioSciences Inc
21/11/202223h24Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:IMGOImago BioSciences Inc
21/11/202220h35Dow Jones NewsTrending: Merck to Acquire Imago BioSciences for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202216h32Dow Jones NewsImago BioSciences Shares Take Flight on Takeover by MerckNASDAQ:IMGOImago BioSciences Inc
21/11/202215h16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:IMGOImago BioSciences Inc
21/11/202213h47TipRanksMerck Snaps Up Imago for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202213h29Dow Jones NewsMerck to Buy Imago for $36 A Share, More Than Double Friday's CloseNASDAQ:IMGOImago BioSciences Inc
21/11/202212h45Business WireMerck to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
11/11/202212h26TipRanksImago BioSciences (IMGO) Receives a Buy from H.C. WainwrightNASDAQ:IMGOImago BioSciences Inc
09/11/202222h25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGOImago BioSciences Inc
09/11/202222h05GlobeNewswire Inc.Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNASDAQ:IMGOImago BioSciences Inc
07/11/202222h05GlobeNewswire Inc.Imago BioSciences to Participate in Upcoming Investor ConferencesNASDAQ:IMGOImago BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:IMGO

Dernières Valeurs Consultées

BIT
F38567
Vontobel Financial Produ...
BOV
CSNAL15
CSNAL15 Ex:12,19
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés